-
1
-
-
0028809308
-
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
-
Grady D, Gebretsadik T, Kerlikowske K, et al., Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85: 304-13.
-
(1995)
Obstet Gynecol
, vol.85
, pp. 304-313
-
-
Grady, D.1
Gebretsadik, T.2
Kerlikowske, K.3
-
2
-
-
84869503034
-
Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
-
Trabert B, Wentzensen N, Yang HP, et al., Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer 2013; 132: 417-26.
-
(2013)
Int J Cancer
, vol.132
, pp. 417-426
-
-
Trabert, B.1
Wentzensen, N.2
Yang, H.P.3
-
3
-
-
18144421167
-
Endometrial cancer and hormone-replacement therapy in the Million Women Study
-
Beral V, Bull D, Reeves G, et al., Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005; 365: 1543-51.
-
(2005)
Lancet
, vol.365
, pp. 1543-1551
-
-
Beral, V.1
Bull, D.2
Reeves, G.3
-
4
-
-
84899917635
-
Menopausal hormone therapy and risk of endometrial cancer
-
Brinton LA, Felix AS., Menopausal hormone therapy and risk of endometrial cancer. J Steroid Biochem Mol Biol 2014; 142: 83-9.
-
(2014)
J Steroid Biochem Mol Biol
, vol.142
, pp. 83-89
-
-
Brinton, L.A.1
Felix, A.S.2
-
5
-
-
79952115034
-
Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into cancer and nutrition
-
Allen NE, Tsilidis KK, Key TJ, et al., Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into cancer and nutrition. Am J Epidemiol 2010; 172: 1394-403.
-
(2010)
Am J Epidemiol
, vol.172
, pp. 1394-1403
-
-
Allen, N.E.1
Tsilidis, K.K.2
Key, T.J.3
-
6
-
-
0030862208
-
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas
-
Sherman ME, Sturgeon S, Brinton LA, et al., Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol 1997; 10: 963-8.
-
(1997)
Mod Pathol
, vol.10
, pp. 963-968
-
-
Sherman, M.E.1
Sturgeon, S.2
Brinton, L.A.3
-
7
-
-
0034083599
-
Theories of endometrial cancer carcinogenesis: A multidisciplinary approach
-
Sherman ME., Theories of endometrial cancer carcinogenesis: a multidisciplinary approach. Mod Pathol 2000; 13: 295-308.
-
(2000)
Mod Pathol
, vol.13
, pp. 295-308
-
-
Sherman, M.E.1
-
8
-
-
84872225562
-
Endometrial cancer risk factors by 2 main histologic subtypes. the NIH-AARP diet and health study
-
Yang HP, Wentzensen N, Trabert B, et al., Endometrial cancer risk factors by 2 main histologic subtypes. The NIH-AARP diet and health study. Am J Epidemiol 2013; 177: 142-51.
-
(2013)
Am J Epidemiol
, vol.177
, pp. 142-151
-
-
Yang, H.P.1
Wentzensen, N.2
Trabert, B.3
-
9
-
-
67651030608
-
Hormone therapy and ovarian cancer
-
Mørch LS, Løkkegaard E, Andreasen AH, et al., Hormone therapy and ovarian cancer. JAMA 2009; 302: 298-305.
-
(2009)
JAMA
, vol.302
, pp. 298-305
-
-
Mørch, L.S.1
Løkkegaard, E.2
Andreasen, A.H.3
-
10
-
-
35648954236
-
Hormone replacement therapy in Denmark, 1995-2004
-
Løkkegaard E, Lidegaard O, Møller LN, et al., Hormone replacement therapy in Denmark, 1995-2004. Acta Obstet Gynecol Scand 2007; 86: 1342-51.
-
(2007)
Acta Obstet Gynecol Scand
, vol.86
, pp. 1342-1351
-
-
Løkkegaard, E.1
Lidegaard, O.2
Møller, L.N.3
-
11
-
-
42149136283
-
Using prescription registries to define continuous drug use: How to fill gaps between prescriptions
-
Nielsen LH, Løkkegaard E, Andreasen AH, et al., Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Pharmacoepidemiol Drug Saf 2008; 17: 384-8.
-
(2008)
Pharmacoepidemiol Drug Saf
, vol.17
, pp. 384-388
-
-
Nielsen, L.H.1
Løkkegaard, E.2
Andreasen, A.H.3
-
12
-
-
78449286682
-
Factors associated with type i and type II endometrial cancer
-
Felix AS, Weissfeld JL, Stone RA, et al., Factors associated with type I and type II endometrial cancer. Cancer Causes Control 2010; 21: 1851-6.
-
(2010)
Cancer Causes Control
, vol.21
, pp. 1851-1856
-
-
Felix, A.S.1
Weissfeld, J.L.2
Stone, R.A.3
-
13
-
-
3042811414
-
Prognostic parameters of endometrial carcinoma
-
Prat J., Prognostic parameters of endometrial carcinoma. Hum Pathol 2004; 35: 649-62.
-
(2004)
Hum Pathol
, vol.35
, pp. 649-662
-
-
Prat, J.1
-
14
-
-
0037738736
-
Endometrial cancer
-
Kurman R.J. ed. 5th edn. New York: Springer
-
Ronnett BM, Zaino R, Ellenson LH, et al., Endometrial cancer. In:, Kurman RJ, ed. Blaustein's pathology of the female genital tract, 5th edn. New York: Springer, 2002. 501-59.
-
(2002)
Blaustein's Pathology of the Female Genital Tract
, pp. 501-559
-
-
Ronnett, B.M.1
Zaino, R.2
Ellenson, L.H.3
-
16
-
-
0029089461
-
Applying Cox regression to competing risks
-
Lunn M, McNeil D., Applying Cox regression to competing risks. Biometrics 1995; 51: 524-32.
-
(1995)
Biometrics
, vol.51
, pp. 524-532
-
-
Lunn, M.1
McNeil, D.2
-
17
-
-
0027159206
-
Joint analysis of site-specific cancer risks for the atomic bomb survivors
-
Pierce DA, Preston DL., Joint analysis of site-specific cancer risks for the atomic bomb survivors. Radiat Res 1993; 134: 134-42.
-
(1993)
Radiat Res
, vol.134
, pp. 134-142
-
-
Pierce, D.A.1
Preston, D.L.2
-
18
-
-
0020660717
-
Two pathogenetic types of endometrial carcinoma
-
Bokhman JV., Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15: 10-17.
-
(1983)
Gynecol Oncol
, vol.15
, pp. 10-17
-
-
Bokhman, J.V.1
-
19
-
-
84883854572
-
Type i and II endometrial cancers: Have they different risk factors?
-
Setiawan VW, Yang HP, Pike MC, et al., Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013; 31: 2607-18.
-
(2013)
J Clin Oncol
, vol.31
, pp. 2607-2618
-
-
Setiawan, V.W.1
Yang, H.P.2
Pike, M.C.3
-
20
-
-
84906937868
-
Why the product labeling on low dose vaginal estrogen should be changed
-
1 6
-
Manson JE, Goldstein SR, Kagan R, et al., Why the product labeling on low dose vaginal estrogen should be changed. Menopause 2014; 21: 911 -1 6.
-
(2014)
Menopause
, vol.21
, pp. 911
-
-
Manson, J.E.1
Goldstein, S.R.2
Kagan, R.3
-
21
-
-
73349103184
-
Endometrial cancer in postmenopausal women using estrogen-progestin therapy
-
Jaakkola S, Lyytinen H, Pukkala E, et al., Endometrial cancer in postmenopausal women using estrogen-progestin therapy. Obstet Gynaecol 2009; 114: 1197-204.
-
(2009)
Obstet Gynaecol
, vol.114
, pp. 1197-1204
-
-
Jaakkola, S.1
Lyytinen, H.2
Pukkala, E.3
-
22
-
-
79551484149
-
Endometrial cancer associated with various forms of postmenopausal hormone therapy: A case control study
-
Jaakkola S, Lyytinen HK, Dyba T, et al., Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study. In J Cancer 2011; 128: 1644-51.
-
(2011)
In J Cancer
, vol.128
, pp. 1644-1651
-
-
Jaakkola, S.1
Lyytinen, H.K.2
Dyba, T.3
-
23
-
-
33947506942
-
Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AAA Diet and Health Study
-
Lacey JV, Leitzmann MF, Chang SC, et al., Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AAA Diet and Health Study. Cancer 2007; 109: 1303-11.
-
(2007)
Cancer
, vol.109
, pp. 1303-1311
-
-
Lacey, J.V.1
Leitzmann, M.F.2
Chang, S.C.3
-
24
-
-
22244447072
-
Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women
-
Lacey JV, Brinton LA, Lubin JH, et al., Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005; 14: 1724-31.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1724-1731
-
-
Lacey, J.V.1
Brinton, L.A.2
Lubin, J.H.3
-
25
-
-
0023934696
-
Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures
-
Storm HH., Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988; 17: 44-9.
-
(1988)
Int J Epidemiol
, vol.17
, pp. 44-49
-
-
Storm, H.H.1
-
26
-
-
0030678495
-
The Danish cancer register - History, content, quality, and use
-
Storm HH, Michelsen EV, Clemmensen IH, et al., The Danish cancer register-history, content, quality, and use. Dan Med Bull 1997; 44: 535-9.
-
(1997)
Dan Med Bull
, vol.44
, pp. 535-539
-
-
Storm, H.H.1
Michelsen, E.V.2
Clemmensen, I.H.3
-
27
-
-
0036685874
-
Validity of breast cancer in the Danish cancer register. A study based on clinical records from one county in Denmark
-
Jensen AR, Overgaard J, Storm HH., Validity of breast cancer in the Danish cancer register. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002; 11: 359-64.
-
(2002)
Eur J Cancer Prev
, vol.11
, pp. 359-364
-
-
Jensen, A.R.1
Overgaard, J.2
Storm, H.H.3
-
28
-
-
77956978331
-
Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort
-
Canchola AJ, Chang ET, Bernstein L, et al., Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes Control 2010; 21: 1407-16.
-
(2010)
Cancer Causes Control
, vol.21
, pp. 1407-1416
-
-
Canchola, A.J.1
Chang, E.T.2
Bernstein, L.3
-
30
-
-
0037541419
-
Age at natural menopause and all-cause mortality: A 37-year follow-up of 19,731 Norwegian women
-
Jacobsen BK, Heuch I, Kvåle G., Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003; 157: 923-9.
-
(2003)
Am J Epidemiol
, vol.157
, pp. 923-929
-
-
Jacobsen, B.K.1
Heuch, I.2
Kvåle, G.3
-
31
-
-
0030296073
-
Hormone replacement therapy and previous use of oral contraceptives among Swedish women
-
Hammer M, Brynhildsen Dabrosin L, Frisk J, et al., Hormone replacement therapy and previous use of oral contraceptives among Swedish women. Maturitas 1996; 25: 193-9.
-
(1996)
Maturitas
, vol.25
, pp. 193-199
-
-
Hammer, M.1
Brynhildsen Dabrosin, L.2
Frisk, J.3
|